These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25890393)

  • 1. Prognostic risk factors for small cell carcinoma of the cervix and impact of platinum-based neoadjuvant chemotherapy.
    Li X; Yang R; Jia Y; Zhou J; Ma D; Li S
    Int J Gynaecol Obstet; 2015 Jul; 130(1):31-5. PubMed ID: 25890393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments.
    Kawamura M; Koide Y; Murai T; Ishihara S; Takase Y; Murao T; Okazaki D; Yamaguchi T; Uchiyama K; Itoh Y; Kodaira T; Shibamoto Y; Mizuno M; Kikkawa F; Naganawa S
    BMC Cancer; 2021 Sep; 21(1):1046. PubMed ID: 34556082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis.
    Hu T; Wu L; Xing H; Yang R; Li X; Huang K; Jia Y; Zhang Q; Chen Z; Wang S; Liu D; Han X; Lin Z; Qu P; Cai H; Song X; Tian X; Wang H; Wang S; Xie X; Li S; Ma D
    Ann Surg Oncol; 2013 Mar; 20(3):881-90. PubMed ID: 23054110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary surgery versus primary radiation therapy for FIGO stages I-II small cell carcinoma of the uterine cervix: A retrospective Taiwanese Gynecologic Oncology Group study.
    Chen TC; Huang HJ; Wang TY; Yang LY; Chen CH; Cheng YM; Liou WH; Hsu ST; Wen KC; Ou YC; Hung YC; Lai HC; Ho CM; Chang TC
    Gynecol Oncol; 2015 Jun; 137(3):468-73. PubMed ID: 25797082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
    Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of effects and postoperative clinicopathological prognosis factors of neoadjuvant chemotherapy in patients with stage Ⅰb2 and Ⅱa2 squamous cell carcinoma of the cervix].
    An JS; Zhao YX; Song Y; Li N; Huang MN; Li XG; Li B; Zhang R; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Oct; 54(10):673-679. PubMed ID: 31648443
    [No Abstract]   [Full Text] [Related]  

  • 7. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
    Li X; Zhou J; Huang K; Tang F; Zhou H; Wang S; Jia Y; Sun H; Ma D; Li S
    PLoS One; 2015; 10(4):e0122361. PubMed ID: 25860888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
    Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
    Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.
    Chan JK; Loizzi V; Burger RA; Rutgers J; Monk BJ
    Cancer; 2003 Feb; 97(3):568-74. PubMed ID: 12548598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
    Lee JM; Lee KB; Nam JH; Ryu SY; Bae DS; Park JT; Kim SC; Cha SD; Kim KR; Song SY; Kang SB
    Ann Oncol; 2008 Feb; 19(2):321-6. PubMed ID: 17962205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix.
    Lee SW; Lim KT; Bae DS; Park SY; Kim YT; Kim KR; Nam JH
    Gynecol Obstet Invest; 2015; 79(3):172-8. PubMed ID: 25500455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and treatment comparison in small cell neuroendocrine cervical carcinoma.
    Yin ZM; Yu AJ; Wu MJ; Zhu JQ; Zhang X; Chen JH; Yuan SH; Yu H
    Eur J Gynaecol Oncol; 2014; 35(3):259-63. PubMed ID: 24984537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The local treatment modalities in FIGO stage I-II small-cell carcinoma of the cervix are determined by disease stage and lymph node status.
    Zhou J; Yang HY; Wu SG; He ZY; Lin HX; Sun JY; Li Q; Guo ZW
    Cancer Med; 2016 Jun; 5(6):1108-15. PubMed ID: 26990881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival following neoadjuvant chemotherapy and concomitant radiochemotherapy in locally advanced cervical cancer: results of the Oncology Institute "Prof. Dr. Ion Chiricuta" experience.
    Marita A; Ordeanu C; Rancea A; Nicolae T; Nagy VM
    J Med Life; 2018; 11(1):42-50. PubMed ID: 29696064
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2-IIB cervical cancer.
    Gong L; Lou JY; Wang P; Zhang JW; Liu H; Peng ZL
    Int J Gynaecol Obstet; 2012 Apr; 117(1):23-6. PubMed ID: 22265255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological Aspects of Small Cell Neuroendocrine Carcinoma of the Uterine Cervix: a Multicenter Retrospective Study and Meta-Analysis.
    Xu F; Ma J; Yi H; Hu H; Fan L; Wu P; Chen X; Wu X; Yu L; Xing H; Wang W
    Cell Physiol Biochem; 2018; 50(3):1113-1122. PubMed ID: 30355937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative adjuvant radiation improves local control in surgically treated FIGO stage I-II small cell carcinoma of the cervix.
    Shen T; Jiang YH; Zou YY; Qiu FF; Qiu XS; You KY
    Radiat Oncol; 2019 Nov; 14(1):203. PubMed ID: 31722727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
    Zivanovic O; Leitao MM; Park KJ; Zhao H; Diaz JP; Konner J; Alektiar K; Chi DS; Abu-Rustum NR; Aghajanian C
    Gynecol Oncol; 2009 Mar; 112(3):590-3. PubMed ID: 19110302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
    Xiong Y; Liang LZ; Cao LP; Min Z; Liu JH
    Gynecol Oncol; 2011 Oct; 123(1):99-104. PubMed ID: 21741694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.